In the most recent issue of JAMA, Dr. Sandra Lin and colleagues published a systematic review of 63 randomized controlled trials evaluating the effectiveness and safety of sublingual immunotherapy for allergies and asthma. The evidence supports the use of sublingual immunotherapy for these conditions despite the lack of information on dosing and adverse reactions. What recommendations do you currently make to your patients inquiring about sublingual immunotherapy ?

For additional information, please click here.